According to the current analysis of Reports and Data, the Point of Care (POC) Hemoglobin Analyzer market was valued at USD 877.3 Million in 2020 and is expected to reach USD 2,031.7 Million by year 2028, at a CAGR of 10.90%. Increasing incidences of anemia and other related illnesses across the world, increasing demand for blood glucose level meters, and increased awareness about Point of Care Hemoglobin Analyzers is bolstering industry growth.
Anemia is widely prevalent in the developing world and is a public health challenge in many countries. Hemoglobin (Hb) assessment is a reliable indicator for anemia screening. However, there are multiple techniques with different applications available for Point of Care Hemoglobin Analyzer and through normal techniques. Direct cyanmethemoglobin method has been the most popular method for hemoglobin estimation but other methods like hemoglobin color scale, Sahli technique, Lovibond-Drabkin technique, Tallqvist technique, copper-sulfate method, HemoCue and automated haematology analyzers are also available. Each method has a different working principle and its own advantages and disadvantages. It has been observed that Non-invasive methods of estimation like HemoCue is apt for initial screening of anemia because it is reliable, portable, does not require power supply and easy to use in poor resource settings without requiring extensive training of health workers. Hemoglobin color scale developed by HCS is another potential method that can be used in field situations. New novel product developments like these tailored for the developing world are expected to drive industry growth.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2160
North America and Europe are expected to occupy significant market share during the forecast period Point of Care Hemoglobin Analyzer industry. These regions have well developed economies and significant investments in R&D is made by each country. Hospitals and clinics are well-equipped and Point of Care Hemoglobin Analyzer device usage is very common. Point of Care Hemoglobin Analyzer market growth will also be propelled by the Asia-Pacific region and parts of Africa. In these regions, incidences of anemia are very high and regular blood testing is required to monitor the prognosis of the disease. Point of Care Hemoglobin Analyzer devices like the DiaSpect Tm, manufactured by EKF Diagnostics are popular in these parts as the machine is portable, low-cost and provides a reliable measure of blood Hb levels. More R&D is however required to make similar Point of Care Hemoglobin Analyzer products available in these regions at a lower cost.
Further key findings from the report suggest:
- Point of Care Hemoglobin Analyzer machines operating on Non-Invasive methods are expected to see maximum growth rate during the forecast period. Growth is being augmented by convenience and ease of operation that these machines provide to patients. Point of Care Hemoglobin Analyzer are easier to use that previous bulky versions. Also, results could be read by the patient easily
- North America had the largest share in the Point of Care Hemoglobin Analyzer industry in 2018, chiefly because of a high disposable income, a greater awareness about diseases in the population, high investments in research and development and more companies operating in the marketplace
- Asia Pacific region will witness the highest CAGR during the forecast period on account of greater population and more incidence of diseases. There is also an urgent need to supply Clinics and Diagnostic centers in the region with point-of-care hemoglobin meters which could measure other diseases like diabetes and HIV
- Regions in Africa and Latin America are also expected to see accelerated growth. For example, Brazil is enacting new regulations and setting standards to expedite the process of point-of care device adoption. The Brazilian medical device market regulator ANVISA recently discussed revisions to planned requirements for custom-made devices, which included POC machines. Under the new regulatory system, patient-specific devices will require only registration with ANVISA, after which they could be marketed
- The Point of Care Hemoglobin Analyzer industry is dependent on point of care diagnostic market in general. Point of Care Hemoglobin Analyzer machines, although easily available in most countries, are bound by stringent laws relating to their usage in certain settings. The lack of standardized laws in many developing countries could be a significant market restraint
- By Applications, Anemia diagnosis occupies the largest market share for the Point of Care Hemoglobin Analyzer industry. Due to greater multi-functionality of Point of Care Hemoglobin Analyzer machines, the demand for diabetes, HIV and other types of testing is also increasing
- Hospitals are the largest buyers and users of these Point of Care Hemoglobin Analyzer products. Most hospitals are large institutional buyers and have huge demand for these machines. They have specialized diagnostic divisions which are involved only in testing services. The demand from hospitals will be a major growth driver for the industry
- Personal user sub-segment is also increasingly becoming an important End User, showing lucrative growth during the forecast period. Due to convenience and ease-of-operation, this sub-segment is seeing augmented growth. The easy availability of many of these products on online channels makes it convenient for people to buy them. Most of these Point of Care Hemoglobin Analyzer machines, especially the non-invasive ones, do not require supervision during their operation
Research Methodology:
Reports and Data utilizes a unique approach to research to offer a comprehensive overview of the global Point of Care Hemoglobin Analyzer Market to offer insights into investment opportunities for stakeholders, investors, clients, and businesses to make informed decisions. The report includes SWOT analysis, Porter’s Five Forces analysis, feasibility analysis, and investment return analysis to offer a better understanding of the market scenario.
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2160
Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in the healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register the highest market growth over the forecast period attributed to the increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.
The growing popularity of over-the-counter medications driving market growth
Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.
Restriction on product launches and R&D activities to hamper the market growth
The imposition of strict government regulations and shortage of funds has put a halt on product launches and R&D activities and is expected to restrain market growth over the forecast period. In addition, the launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering the market growth.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, mergers and acquisitions, collaborations, and joint ventures to gain a robust footing in the market.
Top Companies Profiled in the Report:
- HemoCue Diagnostics (A Danaher Company)
- EKF Diagnostics
- Abbott Laboratories
- Infopia Co Ltd
- Empatica Inc.
- Roche Holding AG
- Ceragem Medisys
- Convergent Technologies
- Trinity Biotech Plc
- I-Sens Inc.,
Point of Care Hemoglobin Analyzer Market Segmentation:
Method Outlook:
- Invasive methods
- Direct cyanmethemoglobin method
- HemoCue method
- Sahli’s method
- Hb color scale method
- Copper sulphate method
- Non- Invasive methods
- Occlusion spectroscopy
- Pulse co-oximetry
- Trancutaneous Reflection Spectroscopy
- Others
Application Outlook:
- Diabetes diagnosis
- Anemia diagnosis
- Others
End-use Outlook:
- Hospitals
- Personal Use
- Diagnostic Centers
- Others
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)
Frequently asked questions addressed in the report:
- What is the revenue growth rate of the global Point of Care Hemoglobin Analyzer market over the forecast period?
- What are the major factors driving the growth of the Global Point of Care Hemoglobin Analyzer Market?
- What are the key challenges impacting the global Point of Care Hemoglobin Analyzer market growth?
- What are the outcomes of the SWOT Analysis and Porter’s Five Forces Analysis conducted in the report?
Request customization on the report @ https://www.reportsanddata.com/request-customization-form/2160
Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.
Explore Latest Trending Research Reports By Reports and Data:
Thyroid Function Tests Market @ https://www.biospace.com/article/thyroid-function-tests-market-growth-2022-2028-increasing-prevalence-of-thyroid-disorders-growing-awareness-regarding-thyroid-function-tests-and-rising-need-for-early-detection-/
Tangential Flow Filtration Market @ https://www.biospace.com/article/tangential-flow-filtration-market-growth-2022-2028-increasing-investment-in-pharmaceutical-sector-rising-acceptance-of-single-use-technologies/
Diabetes Devices Market @ https://www.biospace.com/article/diabetes-devices-market-growth-2022-2028-technological-advancements-in-insulin-delivery-devices-rapid-development-of-advanced-healthcare-infrastructure-and-rising-awareness-of-diabetes-treatment/
Canine Influenza Vaccine Market @ https://www.biospace.com/article/canine-influenza-vaccine-market-growth-2022-2028-increasing-cases-of-canine-influenza-across-the-globe-is-anticipated-to-propel-the-industry-growth/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs